Anti-F3/Factor III/Tissue Factor/CD142 Antibody (Tisotumab vedotin)
Catalog No.
F1438
Anti-F3/Factor III/Tissue Factor/CD142 Antibody (Tisotumab vedotin)
Featured Products
Tisotumab vedotin is an antibody-drug conjugate (ADC) targeting tissue factor (TF), which is covalently linked to a fully human monoclonal antibody to tissue factor (TF-011) and a microtubule disruptor Monomethyl Auristatin E (MMAE). Tisotumab vedotin has immunomodulatory and anti-tumor activities and can be used for the study of advanced or metastatic solid tumors such as cervical cancer.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.66 kDa
Dry ice
1418731-10-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
TIVDAK, TF-011-vcMMAE, TF-011
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P13726
Human
MMAE
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
The drug-to-antibody ratio (DAR) of the Anti-Tissue Factor /CD142 Reference Antibody (tisotumab vedotin) is 4.2.
F3 / Factor III / Tissue Factor / CD142
Please avoid freeze-thaw cycles.